Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis

Autoimmunity Reviews

Volumn 6, Issue 8, 2007, Pages 524-528

  Punzi, Leonardo ^a   Podswiadek, Marta ^a   Sfriso, Paolo ^a   Oliviero, Francesca ^a   Fiocco, Ugo ^a   Todesco, Silvano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anti TNF therapy; Arthritis; Cytokines; Psoriasis; Psoriatic arthritis

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; BONE RADIOGRAPHY; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ENTHESOPATHY; GENETIC PREDISPOSITION; HUMAN; MUSCULOSKELETAL DISEASE; OSTEOCLASTOGENESIS; PATHOGENESIS; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ARTHRITIS, PSORIATIC; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548511080     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.12.003     Document Type: Review

References (35)

1. Moll J.M.N., and Wright V. Psoriatic arthritis. Semin Arthritis Rheum 3 (1973) 51-78
2. Berthelot J.M. Psoriatic arthritis as a mountain. Reumatismo 55 (2003) 6-15
3. Stevens K.J., Smith S.L., Preston B.J., and Deighton C. Tumoral enthesopathy in psoriasis. Rheumatology (Oxford) 40 (2001) 342-345
4. Dans M., Hivnor C., and van Voorhees A.S. Psoriatic onychopachydermoperiostitis: improvement with etanercept. Br J Dermatol 153 (2005) 858-859
5. Palazzi C., D'Agostino L., D'Amico E., Pennese E., and Petricca A. Asymptomatic erosive peripheral psoriatic arthritis: a frequent finding in Italian patients. Rheumatology 42 (2003) 909-911
6. Punzi L., Pianon M., Rossini P., Schiavon F., and Gambari P.F. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 58 (1999) 226-229
7. Cantini F., Salvarani C., Olivieri I., Macchioni L., Padula A., Falcone C., et al. Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. Clin Exp Rheumatol 19 (2001) 291-296
8. Berthelot J.M., Klarlund M., Mcgonagle D., Bernelot-Moens H.J., Calin A., Harrison B., et al. Lessons from an international survey of paper cases from ten real early arthritis-clinic patients. J Rheumatol 28 (2001) 975-981
9. Berthelot J.M., Bernelot-Moens H.J., Klarlund M., Mc-Gonagle D., Calin A., Schumacher H.R., et al. Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondyloarthropathy. A pilot survey. Clin Exp Rheumatol 20 (2002) 145-150
10. Cervini C., Leardini G., Mathieu A., Punzi L., and Scarpa R. Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 italian patients. Reumatismo 57 (2005) 283-290
11. Gladman D.D., Stafford-Brady F., Chang C.H., Lewandowski K., and Russell M.L. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 17 (1990) 809-812
12. Pipitone N., Kingsley G.H., Manzo A., Scott D.L., and Pitzalis C. Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology (Oxford) 42 (2003) 1138-1148
13. Punzi L., Bertazzolo N., Pianon M., Rizzi E., Rossini P., and Gambari P.F. Value of synovial fluid interleukin-1 beta determination in predicting the outcome of psoriatic arthritis. Ann Rheum Dis 55 (1996) 642-644
14. Mease P.J., Goffe B.S., Metz J., VanderStoep A., Finck B., and Burge D.J. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356 (2000) 385-390
15. Brandt J., and Braun J. Anti-TNF-alpha agents in the treatment of psoriatic arthritis. Expert Opin Biol Ther 6 (2006) 99-107
16. Salvarani C., Olivieri I., Cantini F., Marchesoni A., Punzi L., Scarpa R., et al. Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society. Reumatismo 56 (2004) 136-138
17. Braun J., Pham T., Sieper J., Davis J., van der Linden S., Dougados M., et al. International ASAS consensus statement for the use of anti-tumor necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62 (2003) 817-824
18. Ettehadi P., Greaves M.W., Wallach D., Aderka D., and Camp R.D. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 96 (1994) 146-151
19. Ritchlin C., Haas-Smith S.A., Hicks D., Cappuccio J., Osterland C.K., and Looney R.J. Patterns of cytokine production in psoriatic synovium. J Rheumatol 25 (1998) 1544-1552
20. Laloux L., Voisin M.C., Allain J., Martin N., Kerboull L., Chevalier X., et al. Immunohistological study of enthesis in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60 (2001) 316-321
21. Roux-Lombard P., Punzi L., Hasler F., Bas S., Todesco S., Gallati H., et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 36 (1993) 485-489
22. Hohler T., Kruger A., Schneider P.M., Schopf R.E., Knop J., Rittner C., et al. A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 109 (1997) 562-565
23. Balding J., Kane D., Lingstone W., Mynett-Johnson L., Bresnihan B., Smith O., et al. Cytokine gene polymorphisms: associations with psoriatic arthritis susceptibility and severity. Arthritis Rheum 48 (2003) 1408-1413
24. Punzi L., Pianon M., Bertazzolo N., Fagiolo U., Rizzi E., Rossini P., et al. Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients. Clin Exp Rheumatol 16 (1998) 277-281
25. Panayi G. Immunology of psoriasis and psoriatic arthritis. Baillière's Clin Rheumatol 8 (1994) 419-427
26. Ritchlin C., Haas-Smith S.A., Hicks D., Cappuccio J., Osterland C.K., and Looney R.J. Patterns of cytokine production in psoriatic synovium. J Rheumatol 25 (1998) 1544-1552
27. Danning C.L., Illei G.G., Hitchon C., Greer M.R., Boumpas D.T., and McInnes I.B. Macrophage-derived cytokines and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43 (2000) 1244-1256
28. Fearon U., Reece R., Smith J., Emery P., and Veale D.J. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 878 (1999) 619-621
29. Veale D., Yanni G., Rogers S., Barnes L., Bresnihan B., and Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36 (1993) 893-900
30. Fiocco U., Cozzi L., Chieco-Bianchi F., Rigon C., Vezzu M., Favero E., et al. Vascular changes in psoriatic knee joint synovitis. J Rheumatol 28 (2001) 2480-2486
31. Punzi L., Bertazzolo N., Pianon M., Michelotto M., Cesaro G., and Gambari P.F. The volume of synovial fluid effusion in psoriatic arthritis. Clin Exp Rheumatol 13 (1995) 535-536
32. Canete J.D., Pablos J.L., Sanmarti R., Mallofre C., Marsal S., Maymo J., et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum 50 (2004) 1636-1641
33. Kruithof E., De Rycke L., Roth J., Mielants H., Van den Bosch F., De Keyser F., et al. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondyloarthropathies. Arthritis Rheum 52 (2005) 3898-3909
34. Fiocco U., Ferro F., Vezzu M., Cozzi L., Checchetto C., Sfriso P., et al. Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 64 (2005) 899-905
35. Ritchlin C.T., Haas-Smith S.A., Li P., Hicks D.G., and Schwarz E.M. Mechanisms of TNF-alpha-and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111 (2003) 821-831